| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.05 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.55 | 0.05 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.05 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |